Dose-Escalation Study of AL-39324 Suspension versus Lucentis for the Treatment of Exudative AMD
- Registry ID
- EUCTR2009-015681-55
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- Alcon Research, Ltd.
- Start date
- 2010-03-18
- Completion date
- 2011-06-20
- Last update
- 2026-08-16
Conditions
- Exudative Age-related macular degeneration
Summary
The objective of this study is to assess the safety, tolerability and the effects of treatment on ocular outcomes following a single intravitreal administration of AL-39324 suspension in subjects with exudative AMD.
Locations
View on source registry